Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. Kothe, A. Wulff, P. Heyer, J. Rupp, P. Zabel, K. Dalhoff (Lübeck, Germany). Long term survival and risk factors for gram-negative bacillary aetiology in patients with community-acquired pneumonia. Eur Respir J 2009; 34: Suppl. 53, 3190

Member's Comments

No comment yet.

Related content which might interest you: The main risk factors of the community-acquired pneumonia delayed course Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor Source: Eur Respir J 2004; 24 : 779-785 Year: 2004 Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Factors associated with unknown aetiology in patients with community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 560s Year: 2002 Factors associated with unknown aetiology in patients with community-acquired pneumonia Source: Eur Respir J 2002; 20: 1254-1262 Year: 2002 Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Risk factors of community-acquired pneumonia in children Source: Eur Respir J 2010; 36: 1221-1222 Year: 2010 Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia Source: Eur Respir J 2016; 48: 797-807 Year: 2016 The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007 Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis Source: Eur Respir J 2015; 45: 1353-1363 Year: 2015 Risk factors of paediatric community-acquired pneumonia Source: Eur Respir J 2011; 37: 724-725 Year: 2011 Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Treatment failure of community-acquired pneumonia: risk factors and consequences Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors Source: Eur Respir J 2016; 47:1572-1574 Year: 2016 Factors associated with hospital mortality in community-acquired legionellosis in France Source: Eur Respir J 2012; 39: 963-970 Year: 2012 Ventilator-associated pneumonia: risk factors for antimicrobial-resistant causative pathogens Source: Eur Respir J 2006; 28: Suppl. 50, 785s Year: 2006 Incidence and risk factors of MRSA pneumonia Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Epidemiology, treatment and outcomes of nosocomial pneumonia due to Gram-negative bacteria Source: Eur Respir J 2007; 30: Suppl. 51, 408s Year: 2007 Predictive factors of in-hospital mortality of patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006 Prognostic factors of mortality in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 239s Year: 2003